Fengming Xu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Signaling Pathway

Top Venues

Oxidative medicine and cellular longevity

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Fengming Xu, Hans-Michael Tautenhahn, Olaf Dirsch, Uta Dahmen
Blocking autophagy with chloroquine aggravates lipid accumulation and reduces intracellular energy synthesis in hepatocellular carcinoma cells, both contributing to its anti-proliferative effect. Journal of cancer research and clinical oncology 148 (12) (2022)
Fengming Xu, Hans-Michael Tautenhahn, Olaf Dirsch, Uta Dahmen
Modulation of Autophagy: A Novel "Rejuvenation" Strategy for the Aging Liver. Oxidative medicine and cellular longevity 2021 (2021)